Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other Accumulated Expenses (2024 - 2025)

Historic Other Accumulated Expenses for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $5.3 million.

  • Kestra Medical Technologies' Other Accumulated Expenses changed N/A to $5.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2025, which is 19781.7% up from last year.
  • As of Q4 2025, Kestra Medical Technologies' Other Accumulated Expenses stood at $5.3 million.
  • In the past 5 years, Kestra Medical Technologies' Other Accumulated Expenses ranged from a high of $5.3 million in Q4 2025 and a low of $1.2 million during Q2 2024